Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

Saved in:

Bibliographic Details
Title:	Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.
Authors:	Hong HS; CureVac AG , Tübingen, Germany., Koch SD; CureVac AG , Tübingen, Germany., Scheel B; CureVac AG , Tübingen, Germany., Gnad-Vogt U; CureVac AG , Tübingen, Germany., Schröder A; CureVac AG , Tübingen, Germany., Kallen KJ; CureVac AG , Tübingen, Germany., Wiegand V; CureVac AG , Tübingen, Germany., Backert L; Center for Bioinformatics and Center for Bioinformatics, University of Tübingen , Germany., Kohlbacher O; Center for Bioinformatics and Center for Bioinformatics, University of Tübingen, Germany; Quantitative Biology Center, University of Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany., Hoerr I; CureVac AG , Tübingen, Germany., Fotin-Mleczek M; CureVac AG , Tübingen, Germany., Billingsley JM; Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough , MA, USA.
Source:	Oncoimmunology [Oncoimmunology] 2016 Nov 18; Vol. 5 (12), pp. e1249560. Date of Electronic Publication: 2016 Nov 18 (Print Publication: 2016).
Publication Type:	Journal Article
Journal Info:	Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2162-4011
DOI:	10.1080/2162402X.2016.1249560